Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain: An Open Label Study
Phase of Trial: Phase IV
Latest Information Update: 19 Jun 2012
At a glance
- Drugs Hydromorphone (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 19 Jun 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 19 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 29 Sep 2010 New trial record